Login / Signup

Developing a model to predict individualised treatment for gonorrhoea: a modelling study.

Lucy FindlaterHamish MohammedMaya GobinHelen FiferJonathan RossOliver Geffen ObregonKatherine M E Turner
Published in: BMJ open (2021)
Using demographic and behavioural characteristics, we could not reliably identify a participant subset in which ciprofloxacin or penicillin would be effective. Cefixime resistance was almost universally low; however, substituting ceftriaxone for near-uniform treatment with cefixime risks re-emergence of resistance to cefixime and ceftriaxone. Several subgroups had low azithromycin resistance, but widespread azithromycin monotherapy risks resistance at population level. However, this dataset had limitations; further exploration of individual characteristics to predict resistance to a wider range of legacy antibiotics may still be appropriate.
Keyphrases
  • risk assessment
  • cystic fibrosis
  • open label
  • replacement therapy